SBI Life Insurance Company Ltd

SBI Life Insurance Company Ltd has announced the appointment of M/s. K S Aiyar & Co. and M/s. J Singh & Associates as Joint Statutory Auditors for the Financial Year 2026-27. This reappointment is in accordance with the letter received from the Comptroller & Auditor General of India (C&AG) and complies with SEBI (LODR) Regulations, 2015, and the Companies Act, 2013. Both firms are Chartered Accountants with extensive experience in audit and assurance services.

SBI Life Insurance Company Ltd announced that Mr. Narayan K Seshadri has ceased to be an Independent Director of the company. This cessation is effective from the close of business hours on August 19, 2026, upon completion of his tenure. Mr. Seshadri served two consecutive terms of three years each. The company has provided details as required by SEBI regulations in Annexure A, confirming the reason for cessation is completion of tenure.

SBI Life Insurance Company Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on July 24, 2026. The company's statutory auditors, M/s. K S Aiyar & Co. and M/s. J Singh & Associates, issued unmodified opinions on the limited review reports. The trading window for dealing in the company's securities will reopen on July 27, 2026.

SBI Life Insurance reported standalone Q1 FY27 (quarter ended June 30, 2026) net profit of ₹724.93 Cr, up 22.0% YoY from ₹594.37 Cr, on shareholders'-account income of ₹739.52 Cr (+20.4% YoY). The 9.9% sequential dip from Q4 FY26's ₹804.64 Cr is a seasonality artifact — Q4 is structurally the strongest quarter for life insurers as the surplus transferred from the policyholders' account peaks — not a slowdown; on the YoY lens that matters, this is clean double-digit growth. EPS rose to ₹7.23 from ₹5.93. The results are unaudited but limited-reviewed with an unmodified opinion by joint auditors K S Aiyar & Co. and J Singh & Associates; consolidated figures are not applicable as the company has no subsidiaries. The profit rode a strong topline. Gross written premium grew 19.5% YoY to ₹21,289.65 Cr and net premium 16.9% to ₹20,078.21 Cr, with new business premium (first-year plus single) up 22.6% to ₹8,907.86 Cr — first-year premium alone jumped ~40%. Embedded value stood at ₹85,290 Cr as at 30 June 2026 with value of new business of ₹1,410 Cr for the quarter (independently reviewed by WTW); the VNB margin, reported around 28-29%, sits within-to-above management's 26-28% guide. There were no exceptional or one-off items on either side, so the ~22% reported growth is also the underlying growth. The print tracks management's FY27 outlook from the Q4 concall — ~14% APE growth with VNB margins held at 26-28% through a richer non-ULIP/protection mix — and Q1 new-business momentum runs comfortably ahead of that pace, though APE itself is not disclosed in this quarterly statement. No reliable street consensus for the quarter was available, and management gives no formal profit guidance. Balance-sheet strength is intact: solvency 1.96x (above the 1.50x regulatory floor and up from 1.90x in March) and 13th-month persistency steady at 84.35% on a premium basis (84.24% a year ago). Concurrent corporate actions this quarter — an 8.94-lakh ESOP grant and the 26th AGM slated for August 14, 2026 — are routine. The one structural watch item is the Sahara (SILIC) portfolio: per IRDAI/SAT orders the company maintains separate SILIC books through FY 2026-27, with SILIC's closing balance and transactions to fold into SBI Life's financials from April 1, 2027 (FY 2027-28).

SBI Life Insurance Company Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per SEBI LODR Regulations. The report, which includes a Reasonable Assurance Report from S K Patodia & Associates LLP, details the company's corporate identity, operations, and market reach. SBI Life primarily operates in financial and insurance services, with life insurance contributing 100% of its turnover. The company serves a diverse customer base across 35 locations in India, emphasizing financial inclusion and offering a wide range of insurance and savings solutions. The BRSR is hosted on the company's website and forms part of the Integrated Annual Report.

SBI Life Insurance Company Ltd has announced its 26th Annual General Meeting (AGM) scheduled for Friday, August 14, 2026, at 02:30 PM IST. The meeting will be conducted through Video Conference/Other Audio-Visual Means. The company has also enclosed its Integrated Annual Report for FY 2025-26 and the Notice of the AGM. In compliance with regulatory guidelines, both documents are being circulated electronically to members with registered email IDs and are also available on the company's website. For members without registered email IDs, a letter with web-links to access these documents is being sent. The e-voting facility will be available from August 10 to August 13, 2026, with a cut-off date of August 7, 2026.

SBI Life Insurance Company Ltd has announced its 26th Annual General Meeting (AGM) will be held on Friday, August 14, 2026, at 02:30 PM IST. The meeting will be conducted through Video Conference/Other Audio-Visual Means. The Integrated Annual Report for FY 2025-26 and the AGM notice are being circulated electronically to registered members. E-voting will be open from August 10 to August 13, 2026. The company is also providing web-links for accessing these documents on its website and stock exchanges.

SBI Life Insurance Company Ltd announced that its Board of Directors, in a meeting held on July 13, 2026, has approved the schedule for the 26th Annual General Meeting (AGM). The AGM will take place on Friday, August 14, 2026, at 02:30 P.M. IST. The meeting will be conducted virtually through Video Conference (VC) or Other Audio-Visual Means (OAVM) facility. Further details regarding the AGM will be communicated in the official notice, which will be issued shortly. The board meeting commenced at 05:00 P.M. IST and concluded at 06:00 P.M. IST.

SBI Life Insurance Company Ltd. announced that its Board Nomination and Remuneration Committee has approved the grant of 8,94,910 employee stock options (ESOPs) under the ESOS-2018 scheme. Each option entitles the holder to one equity share of Rs. 10. The exercise price will be the lower of the Fair Market Value (FMV) on the grant date or the average FMV of the preceding 15 trading days. Vesting will occur in proportions of 30%-30%-40%, commencing one year from the grant date. The options are exercisable within seven years from the grant date. This move is in line with SEBI regulations and aims to incentivize eligible employees.

SBI Life Insurance Company Ltd has announced that its Board of Directors will convene on July 24, 2026. The primary agenda for this meeting is to consider and approve the financial results for the quarter ended June 30, 2026. The company will submit the outcome of the board meeting and the financial results as per the Listing Regulations. Additionally, the trading window for the company's securities will remain closed from July 1, 2026, and will reopen 48 hours after the declaration of these financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.